BioXcel Therapeutics (BTAI) Invested Capital (2018 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Invested Capital of $22.4 million for Q1 2026, up 299.98% year-over-year from $5.6 million in Q1 2025, and down 10.03% quarter-over-quarter from $24.9 million in Q4 2025.
BioXcel Therapeutics (BTAI) Invested Capital (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Invested Capital history runs 9 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- In Q1 2026, Invested Capital rose 299.98% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $75.4 million (down 76.73% YoY), while the FY2025 annual figure was $24.9 million, down 76.64% from the prior year.
- Invested Capital for Q1 2026 stood at $22.4 million, down from $24.9 million in the prior quarter.
- The five-year high for Invested Capital was $106.7 million in Q4 2024, with the low at $56000.0 in Q1 2022.
- The 5-year median for Invested Capital is $101.4 million (2022), against an average of $70.1 million.
- The sharpest annual moves came in 2023 and 2025: Invested Capital surged 184033.93% in 2023, then sank 94.6% in 2025.
- BioXcel Therapeutics' Invested Capital stood at $101.4 million in 2022, then rose by 1.23% to $102.7 million in 2023, then advanced by 3.94% to $106.7 million in 2024, then sank by 76.64% to $24.9 million in 2025, then retreated by 10.03% to $22.4 million in 2026.
- Business Quant data shows BTAI's Invested Capital at $22.4 million in Q1 2026, $24.9 million in Q4 2025, and $16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 104.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.45 Mn |
| Mar 31, 2026 | 22.43 Mn |
| Dec 31, 2025 | 24.93 Mn |
| Sep 30, 2025 | 16.82 Mn |
| Jun 30, 2025 | 11.22 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Dec 31, 2024 | 106.72 Mn |
| Sep 30, 2024 | 106.50 Mn |
| Jun 30, 2024 | 105.17 Mn |
| Mar 31, 2024 | 103.90 Mn |
| Dec 31, 2023 | 102.68 Mn |
| Sep 30, 2023 | 106.41 Mn |
| Jun 30, 2023 | 104.54 Mn |
| Mar 31, 2023 | 103.12 Mn |
| Dec 31, 2022 | 101.44 Mn |
| Sep 30, 2022 | 100.40 Mn |
| Jun 30, 2022 | 70.00 Mn |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 154,000.00 |